Biotricity BTCY
OTC BTCY
$0.06 +0.01 (+20.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Biotricity (BTCY) Return on Sales [ROS] (2018 - 2026)

Updated

Biotricity's Return on Sales [ROS] was 3.70% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 3.58 percentage points from 7.28% a year earlier and down 12.64 percentage points from the prior quarter.

Analysis

Biotricity (BTCY) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Biotricity's Return on Sales [ROS] was 9.56% through Jun 30, 2026, up 16.82 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 10.57%, up 28.33 percentage points from FY2025.

  • Return on Sales [ROS] has now increased for seven consecutive fiscal years, with a five-year change of +405.04 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Return on Sales [ROS] was -17.76% in FY2025 (+55.42 pp), -73.18% in FY2024 (+86.68 pp), -159.87% in FY2023 (+58.91 pp) and -218.77% in FY2022 (+175.69 pp).
  • The fiscal Q1 2027 figure marks the lowest quarterly Return on Sales [ROS] since fiscal Q4 2025.
  • Compared with a year earlier, Return on Sales [ROS] was higher in seven of the last eight quarters, with an average year-over-year change of +35.94 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was fiscal Q3 2022 (a gain of 141.97 percentage points); the worst was fiscal Q1 2023 (a drop of 28.66 percentage points).
  • Per Business Quant data, BTCY's Return on Sales [ROS] in the three fiscal quarters before Q1 2027 was 16.34% (Q4 2026), 11.06% (Q3 2026) and 7.05% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 10.44%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 19.44%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 18.08%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 15.86%
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 17.44%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 6.36%
10 Biotricity 1.20 Mn 23,371.47 3.53 Mn 3.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.70%
Mar 31, 2026 16.34%
Dec 31, 2025 11.06%
Sep 30, 2025 7.05%
Jun 30, 2025 7.28%
Mar 31, 2025 -23.10%
Dec 31, 2024 -4.67%
Sep 30, 2024 -9.42%
Jun 30, 2024 -34.88%
Mar 31, 2024 -95.78%
Dec 31, 2023 -43.11%
Sep 30, 2023 -75.59%
Jun 30, 2023 -76.69%
Mar 31, 2023 -125.93%
Dec 31, 2022 -156.09%
Sep 30, 2022 -169.19%
Jun 30, 2022 -198.86%
Mar 31, 2022 -178.25%
Dec 31, 2021 -245.34%
Sep 30, 2021 -286.00%
API Access

Biotricity Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BTCY&period=max&api_key=YOUR_API_KEY